Oral Oncology
Volume 46, Issue 7 , Pages 485-491 , July 2010

Molecular analysis of surgical margins in head and neck cancer: More than a marginal issue

  • Boudewijn J.M. Braakhuis

      Affiliations

    • Department of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Tumor Biology Section, Department of Otolaryngology/Head–Neck Surgery, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. Tel.: +31 20 44 40905; fax: +31 20 44 42033.
    • ,
  • Elisabeth Bloemena

      Affiliations

    • Department of Maxillofacial Surgery/Oral Pathology, Academic Centre of Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands
    • Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • C. René Leemans

      Affiliations

    • Department of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Ruud H. Brakenhoff

      Affiliations

    • Department of Otolaryngology/Head–Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands

Received 13 January 2010 ,Revised 26 January 2010 ,Accepted 27 January 2010.

References 

  1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–316
  2. Braakhuis BJ, Visser O, Leemans CR. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol. 2009;45(9):e85–e89
  3. Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21(3):194–200
  4. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–1389
  5. Slootweg PJ, Hordijk GJ, Schade Y, Van Es RJJ, Koole R. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol. 2002;38(5):500–503
  6. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73(1):187–190
  7. Eckardt A, Barth EL, Kokemueller H, Wegener G. Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period. Oral Oncol. 2004;40(4):427–432
  8. Van Houten VMM, Tabor MP, Van Den Brekel MWM, Kummer JA, Denkers F, Dijkstra J, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol. 2002;198(4):476–486
  9. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res. 2004;10(11):3607–3613
  10. Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res. 2001;7(6):1523–1532
  11. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000;6(2):357–362
  12. Partridge M, Pateromichelakis S, Phillips E, Emilion G, Langdon J. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma. Clin Cancer Res. 2001;7(7):1860–1866
  13. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter’s concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63(8):1727–1730
  14. Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck. 2002;24(2):198–206
  15. Van Houten VMM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, Van Den Brekel MWM, et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res. 2004;10(11):3614–3620
  16. Woolgar JA, Triantafyllou A. A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. Oral Oncol. 2005;41(10):1034–1043
  17. Batsakis JG. Surgical excision margins: a pathologist’s perspective. Adv Anat Pathol. 1999;6(3):140–148
  18. Meier JD, Oliver DA, Varvares MA. Surgical margin determination in head and neck oncology: current clinical practice. The results of an international American head and neck society member survey. Head Neck. 2005;27(11):952–958
  19. Looser KG, Shah JP, Strong EW. The significance of positive margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1978;1(2):107–111
  20. Mcmahon J, O’brien CJ, Pathak I, Hamill R, Mcneil E, Hammersley N, et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. 2003;41(4):224–331
  21. Kovacs AF. Relevance of positive margins in case of adjuvant therapy of oral cancer. Int J Oral Maxillofac Surg. 2004;33(5):447–453
  22. Gonzalez-Garcia R, Naval-Gias L, Roman-Romero L, Sastre-Perez J, Rodriguez-Campo FJ. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients. Head Neck. 2009;31(9):1168–1180
  23. Bradford CR, Wolf GT, Fisher SG, Mcclatchey KD. Prognostic importance of surgical margins in advanced laryngeal squamous carcinoma. Head Neck. 1996;18(1):11–16
  24. Cook JA, Jones AS, Phillips DE, Lluch ES. Implications of tumor in resection margins following surgical-treatment of squamous-cell carcinoma of the head and neck. Clin Otolaryngol. 1993;18(1):37–41
  25. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2003;32(1):30–34
  26. Binahmed A, Nason RW, Abdoh AA. The clinical significance of the positive surgical margin in oral cancer. Oral Oncol. 2007;43(8):780–784
  27. Liao CT, Chang JTC, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol. 2008;15(3):915–922
  28. Nason RW, Binahmed A, Pathak KA, Abdoh AA, Sandor GKB. What is the adequate margin of surgical resection in oral cancer?. Oral Surg Oral Med O. 2009;107(5):625–629
  29. Brandwein-Gensler A, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, et al. Oral squamous cell carcinoma – histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29(2):167–178
  30. Kademani D, Bell RB, Bagheri S, Holmgren E. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg. 2005;63(11):1599–1605
  31. Schaaij-Visser TB, Graveland AP, Gauci S, Braakhuis BJ, Buijze M, Heck AJ, et al. Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res. 2009;15(24):7666–7675
  32. Sinha P, Bahadur S, Thakar A, Matta A, Macha M, Ralhan R, et al. Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue. Head Neck. 2009;31(11):1423–1430
  33. Weijers M, Snow GB, Bezemer PD, Van Der Wal JE, Van Der Waal I. The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients. J Oral Pathol Med. 2002;31(1):11–15
  34. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008;37(3):127–133
  35. Tabor MP, Braakhuis BJ, van der Wal JE, van Diest PJ, Leemans CR, Brakenhoff RH, et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol. 2003;199(3):354–360
  36. Bosman FT. Dysplasia classification: pathology in disgrace?. J Pathol. 2001;194(2):143–144
  37. Voravud N, Shin DM, Ro JY, Lee JS, Hong WK, Hittelman WN. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res. 1993;53(12):2874–2883
  38. Barrera JE, Ai H, Pan ZX, Meyers AD, VarellaGarcia M. Malignancy detection by molecular cytogenetics in clinically normal mucosa adjacent to head and neck tumors. Arch Otolaryngol Head Neck Surg. 1998;124(8):847–851
  39. Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, et al. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 1998;17(18):2313–2322
  40. Stafford ND, Ashman JN, MacDonald AW, Ell SR, Monson JR, Greenman J. Genetic analysis of head and neck squamous cell carcinoma and surrounding mucosa. Arch Otolaryngol Head Neck Surg. 1999;125(12):1341–1348
  41. Jin XJ, Zhou L, Zhao AG. Mutants of p53 gene presence in laryngeal carcinoma and adjacent histopathologically normal tissue. ORL J Otorhinolaryngol. 2000;62(3):140–142
  42. Cruz IB, Cjlm Meijer, Snijders PJF, Snow GB, Walboomers JMM, Van Der Waal I, et al. p53 Immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management. J Pathol. 2000;191(2):132–137
  43. Van Der Toorn PPG, Veltman JA, Bot FJ, De Jong JMA, Manni JJ, Ramaekers FCS, et al. Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)malignant cells. J Pathol. 2001;193(1):66–72
  44. Ott CE, Skroch E, Steinhart H, Verdorfer I, Pahl S, Iro H, et al. Thin section arrays for I-FISH analysis of chromosome-specific imbalances in squamous cell carcinomas of the head and neck. Int J Oncol. 2002;20(3):623–630
  45. Fabricius EM, Gurr U, Wildner GP. Telomerase activity levels in the surgical margin and tumour distant tissue of the squamous cell carcinoma of the head-and-neck. Anal Cell Pathol. 2002;24(1):25–39
  46. Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130(1):39–44
  47. Szukala K, Brieger J, Bruch K, Biczysko W, Wierzbicka M, Szyfter W, et al. Loss of heterozygosity on chromosome arm 13q in larynx cancer patients: analysis of tumor, margin and clinically unchanged mucosa. Med Sci Monitor. 2004;10(6):CR233–CR240
  48. Preuss SF, Brieger J, Essig EK, Stenzel MJ, Mann WJ. Quantitative DNA measurement in oropharyngeal squamous cell carcinoma and surrounding mucosa. ORL J Otorhinolaryngol. 2004;66(6):320–324
  49. Brieger J, Kastner J, Gosepath J, Mann WJ. Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma. Cancer Genet Cytogenet. 2006;167(1):26–31
  50. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res. 2006;12(22):6716–6722
  51. Szukala K, Sowinska A, Wierzbicka M, Biczysko W, Szyfter W, Szyfter K. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?. Mutat Res. 2006;600(1–2):67–76
  52. Martone T, Gillio-Tos A, De Marco L, Fiano V, Maule M, Cavalot A, et al. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res. 2007;13(17):5089–5094
  53. Tunca B, Erisen L, Coskun H, Cecener G, Ozuysal S, Egeli U. P53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck. Tumori. 2007;93(2):182–188
  54. Bremmer JF, Braakhuis BJM, Brink A, Broeckaert MAM, Belien JAM, Meijer GA, et al. Comparative evaluation of genetic assays to identify oral pre-cancerous fields. J Oral Pathol Med. 2008;37(10):599–606
  55. Bilde A, Von Buchwald C, Dabelsteen E, Therkildsen MH, Dabelsteen S. Molecular markers in the surgical margin of oral carcinomas. J Oral Pathol Med. 2009;38(1):72–78
  56. Graveland AP, De Maaker M, Braakhuis BJM, De Bree R, Eerenstein SEJ, Bloemena E, et al. Molecular detection of minimal residual cancer in surgical margins of head and neck cancer patients. Cell Oncol. 2009;31(4):317–328
  57. Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S. Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med. 2009;38(10):737–752
  58. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332(7):429–435
  59. Nathan CAO, Franklin S, Abreo FW, Nassar R, DeBenedetti A, Glass J. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J Clin Oncol. 1999;17(9):2909–2914
  60. Nathan CAO, Sanders K, Abreo FW, Nassar R, Glass J. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res. 2000;60(13):3599–3604
  61. Partridge M, Li SR, Pateromichelakis S, Francis R, Phillips E, Huang XH, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res. 2000;6(7):2718–2725
  62. Sardi I, Franchi A, Ferriero G, Frittelli A, Bruschini L, Montali E, et al. Prediction of recurrence by microsatellite analysis in head and neck cancer. Gene Chromosome Cancer. 2000;29(3):201–206
  63. Temam S, Casiraghi O, Lahaye JB, Bosq J, Zhou X, Julieron M, et al. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma. Clin Cancer Res. 2004;10(12):4022–4028
  64. Handschel J, Oz D, Pomjanski N, Depprich R, Ommerborn MA, Braunstein S, et al. Additional use of DNA-image cytometry improves the assessment of resection margins. J Oral Pathol Med. 2007;36(8):472–475
  65. Huang X, Pateromichelakis S, Hills A, Sherriff M, Lyons A, Langdon J, et al. P53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins. Clin Cancer Res. 2007;13(20):6099–6106
  66. Tan HK, Saulnier P, Auperin A, Lacroix L, Casiraghi O, Janot F, et al. Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas. Br J Cancer. 2008;99(2):357–363
  67. Zhao HY, Ren J, Zhuo XL, Ye HP, Zou J, Liu SX. Prognostic significance of survivin and cd44v6 in laryngeal cancer surgical margins. J Cancer Res Clin Oncol. 2008;134(10):1051–1058
  68. Bergshoeff VE, Hopman AH, Zwijnenberg IR, Ramaekers FC, Bot FJ, Kremer B, et al. Chromosome instability in resection margins predicts recurrence of oral squamous cell carcinoma. J Pathol. 2008;215(3):347–348
  69. Simon RM, Paik S, Hayes DF. Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst. 2009;101(21):1446–1452
  70. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Van Der Wal JE, Snow GB, Leemans CR, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol. 2002;161(3):1051–1060

PII: S1368-8375(10)00032-1

doi: 10.1016/j.oraloncology.2010.01.019

Oral Oncology
Volume 46, Issue 7 , Pages 485-491 , July 2010

Article Tools